EUCTR2006-001837-16-AT进行中（未招募）不适用
Prulifloxacin versus Levofloxacin in patients with Acute Bacterial Rhinosinusitis (ABRS)
ACRAF S.p.A.0 个研究点目标入组 284 人开始时间: 2007年10月11日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 284
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •male or female adults with no limitation of race: ABRS defined as a viral upper respiratory tract infection characterized by increase of symptoms after 5 days, or persistent symptoms for 10 days before the screening visit, with less than 12 weeks duration; clinical diagnosis of ABRS characterized by the presence of two or more of nasal blockade/congestion, discharge, anterior/post nasal drip, facial pain/pressure, reduction/loss of smell: clinical diagnosis of moderate/severe ABRS; written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Hypersensitivity or allergy to Fluorquinolone antibacterials and/or any component, nosocomial sinus infection or infections following or associated with naso-tracheal intubation, chronic or complicated rhinosinusitis, nasal polyps, history of sinus surgery
研究者
相似试验
进行中（未招募）
1 期
Prulifloxacin versus Levofloxacin in patients with Acute Bacterial Rhinosinusitis (ABRS)Acute Bacterial RhinosinusitisEUCTR2006-001837-16-ROACRAF S.p.A.284
进行中（未招募）
1 期
Prulifloxacin versus Levofloxacin in patients with Acute Bacterial Rhinosinusitis (ABRS)Acute Bacterial RhinosinusitisEUCTR2006-001837-16-HUAngelini Farmaceutici284
进行中（未招募）
不适用
Prulifloxacin versus levofloxacin in the treatment of patients with Acute Exacerbations of Chronic Bronchitis (AECB)EUCTR2006-004167-56-PTA.C.R.A.F. S.p.A.300
进行中（未招募）
不适用
Prulifloxacin versus levofloxacin in the treatment of patients with Acute Exacerbations of Chronic Bronchitis AECB - NDOutpatient with acute exacerbations of chronic bronchitisMedDRA version: 9.1Level: LLTClassification code 10061736Term: Bronchitis bacterialEUCTR2006-004167-56-ITANGELINI284
进行中（未招募）
1 期
Prulifloxacin versus levofloxacin in the treatment of patients with Acute Exacerbations of Chronic Bronchitis (AECB)Acute Exacerbations of Chronic BronchitisMedDRA version: 9.1Level: LLTClassification code 10000743Term: Acute exacerbation of chronic bronchitisEUCTR2006-004167-56-PLA.C.R.A.F. S.p.A.300